Nemaline Myopathy Gene Therapy Research Moves to Next Phase of Pre-Clinical Trials - A Foundation Building Strength
Promising news! Gene therapy research for Nemaline Myopathy (NEM3) progresses with successful pre-clinical trials in mice. Learn more about Dr. Rashnonejad's innovative approach and its potential to offer hope for NEM3 patients.| A Foundation Building Strength
